2022 Symposium Objectives

HPV Vaccination Programs: From Pre-introduction Planning to Restoration and Sustainability

24 – 25 Sept 2022 | Addis Ababa, Ethiopia

What is the CHIC project?

The Coalition to Strengthen the HPV Immunization Community (CHIC) project aims to contribute to the dialogue on science, policy, and program implementation supporting cervical cancer elimination efforts. This aim will be addressed in two ways: 1- setting up meetings and a symposia series in GAVI-eligible countries to stimulate communication between stakeholders advancing science, developing evidence-based policies, and managing programs in and across countries, and 2- creating a dedicated platform to share experiences and draw the research agenda to accelerate progress in HPV vaccine introduction, access, program optimization and sustainability. The project is a collaboration between John Hopkins University (JHU), Jhpiego, the London School of Hygiene & Tropical Medicine (LSHTM), and the University of Antwerp. More information about the project can be found here: www.stophpv.org.

The focus of the CHIC Project: 

Provide and manage a platform that identifies and elevates the voices of low- and middle-income countries (LMICs) to shape global science, policy, and program dialogues on HPV vaccination

Foster the leadership of a robust community of practice around HPV vaccines that connects scientists, decision-makers, and decision-influencers in-country and across regions

Support sustainable introductions and restoration of HPV vaccination programs. 

Aim of the Symposium:

The aim of the CHIC symposium is to facilitate discussion on HPV vaccination programs by inviting key stakeholders from LMICs to engage and share their experiences with HPV vaccination programs. 

Preliminary Objectives of the Symposium:

One of the main objectives of the symposium is to create an HPV community in the global south by engaging countries at different levels of HPV vaccination program introduction to: 

  • Share experiences and lessons learned
  • Discuss evidence-based policies and program management in and across countries
  • Contribute to  the research agenda to accelerate progress in HPV vaccine introduction, access, program optimization, restoration, and sustainability
  • Discuss new developments in the field and health models that can be integrated with HPV vaccination programs
  • Discuss integration of HPV vaccination programs with adolescent health services.